CalciMedica, Inc. CALC

NAS: CALC | ISIN: US38942Q2021 7/08/2025

2,910 USD (-3,00%)

(-3,00%) 7/08/2025

Grafiek CalciMedica, Inc.

Grafiek CalciMedica, Inc.

1 dag1d -3,00%
1 week1w -1,02%
1 maand1m 83,02%
3 maanden3m 41,26%
6 maanden6m 5,82%
1 jaar1j -37,42%
5 jaar5j -98,74%

CalciMedica, Inc. in het nieuws

Toon enkel gratis nieuws

8 juli 2025 · CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference · Persbericht

25 juni 2025 · CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure · Persbericht

12 juni 2025 · CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting · Persbericht

14 mei 2025 · CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates · Persbericht

17 april 2025 · CalciMedica Announces Presentations at Upcoming Medical Meetings · Persbericht

1 april 2025 · CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference · Persbericht

27 maart 2025 · CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates · Persbericht

5 maart 2025 · CalciMedica Secures Credit Facility for Up to $32.5 Million · Persbericht

4 maart 2025 · CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference · Persbericht

3 september 2024 · CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe